Amprius Q3 2026 net loss narrows 10% YoY to $3.5 million; Q3 revenue rises 83% YoY to $39.1 million

By Public Technologies
  • Amprius Technologies’ third-quarter 2026 net loss attributable to common stockholders narrowed 10% year over year to $3.5 million.
  • Revenue climbed 83% year over year to $39.1 million, while gross margin reached 27%.
  • It secured a $75 million U.S. Department of War contract supporting domestic cell production, with planned output starting in 2028.
  • The 2026 revenue outlook rose to $145 million, with net loss expected below $10 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amprius Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611101605BIZWIRE_USPR_____20261110_BW308758) on November 10, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk